November 14, 2022

Experimental therapy gantenerumab fails to slow or improve Alzheimer’s memory loss in clinical trials

An experimental treatment, gantenerumab, failed to help people at high risk of memory loss from Alzheimer’s or those who were in the early phases of the disease, the manufacturer said Monday.

November 8, 2022

T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression – Nature

November 1, 2022

UChicago Scientists Collaborate on ALS Research, Outreach in New Center for Motor Neuron Disease – Chicago Maroon

October 5, 2022

BBC to Air Documentary on Former Rugby Player with Motor Neuron Disease – AFTD – The Association for Frontotemporal Degeneration

September 29, 2022

New Automated Screening Tool Could Mean Earlier, More Effective Treatment for Idiopathic Pulmonary Fibrosis – WCM Newsroom